Lv1
40 积分 2024-12-03 加入
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
9小时前
已完结
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial
5天前
已完结
Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies
5天前
已完结
Claudin 18.2 as a novel therapeutic target
5天前
已完结
Mechanisms of cancer cell death induction by paclitaxel: an updated review
1个月前
已完结
BCS class IV drugs: Highly notorious candidates for formulation development
1个月前
已完结
Paclitaxel (Taxol)
1个月前
已完结
Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial
1个月前
已完结
Trends in clinical development for PD-1/PD-L1 inhibitors
1个月前
已完结
Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea
1个月前
已完结
皖公网安备34019202002308
